These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32314086)

  • 1. Crosstalk between GSK-3β-actuated molecular cascades and myocardial physiology.
    Sharma AK; Bhatia S; Al-Harrasi A; Nandave M; Hagar H
    Heart Fail Rev; 2021 Nov; 26(6):1495-1504. PubMed ID: 32314086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GSK-3 family as therapeutic target for myocardial diseases.
    Lal H; Ahmad F; Woodgett J; Force T
    Circ Res; 2015 Jan; 116(1):138-49. PubMed ID: 25552693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The signaling interplay of GSK-3β in myocardial disorders.
    Sharma AK; Thanikachalam PV; Bhatia S
    Drug Discov Today; 2020 Apr; 25(4):633-641. PubMed ID: 32014454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart.
    Lal H; Ahmad F; Zhou J; Yu JE; Vagnozzi RJ; Guo Y; Yu D; Tsai EJ; Woodgett J; Gao E; Force T
    Circulation; 2014 Jul; 130(5):419-30. PubMed ID: 24899689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
    Palfi A; Toth A; Hanto K; Deres P; Szabados E; Szereday Z; Kulcsar G; Kalai T; Hideg K; Gallyas F; Sumegi B; Toth K; Halmosi R
    J Mol Cell Cardiol; 2006 Jul; 41(1):149-59. PubMed ID: 16716347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
    Hardt SE; Tomita H; Katus HA; Sadoshima J
    Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
    Hirotani S; Zhai P; Tomita H; Galeotti J; Marquez JP; Gao S; Hong C; Yatani A; Avila J; Sadoshima J
    Circ Res; 2007 Nov; 101(11):1164-74. PubMed ID: 17901358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
    Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
    Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway.
    Yao YY; Yin H; Shen B; Smith RS; Liu Y; Gao L; Chao L; Chao J
    Cardiovasc Res; 2008 Dec; 80(3):354-64. PubMed ID: 18689794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK-3 at the heart of cardiometabolic diseases: Isoform-specific targeting is critical to therapeutic benefit.
    Umbarkar P; Ruiz Ramirez SY; Toro Cora A; Tousif S; Lal H
    Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166724. PubMed ID: 37094727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition.
    Miki T; Miura T; Hotta H; Tanno M; Yano T; Sato T; Terashima Y; Takada A; Ishikawa S; Shimamoto K
    Diabetes; 2009 Dec; 58(12):2863-72. PubMed ID: 19755525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.
    Woulfe KC; Gao E; Lal H; Harris D; Fan Q; Vagnozzi R; DeCaul M; Shang X; Patel S; Woodgett JR; Force T; Zhou J
    Circ Res; 2010 May; 106(10):1635-45. PubMed ID: 20360256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in myocardial protection against ischemia/reperfusion injury.
    Miura T; Nishihara M; Miki T
    J Pharmacol Sci; 2009 Feb; 109(2):162-7. PubMed ID: 19179805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development.
    Hardt SE; Sadoshima J
    Circ Res; 2002 May; 90(10):1055-63. PubMed ID: 12039794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise preconditioning and low dose copper nanoparticles exhibits cardioprotection through targeting GSK-3β phosphorylation in ischemia/reperfusion induced myocardial infarction.
    Sharma AK; Kumar A; Sahu M; Sharma G; Datusalia AK; Rajput SK
    Microvasc Res; 2018 Nov; 120():59-66. PubMed ID: 29940198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
    Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ
    Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways.
    Yin H; Chao L; Chao J
    J Biol Chem; 2005 Mar; 280(9):8022-30. PubMed ID: 15611141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
    Menon B; Johnson JN; Ross RS; Singh M; Singh K
    J Mol Cell Cardiol; 2007 Mar; 42(3):653-61. PubMed ID: 17292911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSK-3β/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy.
    Duran J; Oyarce C; Pavez M; Valladares D; Basualto-Alarcon C; Lagos D; Barrientos G; Troncoso MF; Ibarra C; Estrada M
    PLoS One; 2016; 11(12):e0168255. PubMed ID: 27977752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.